CannLabs, Inc. Selects Merriman Capital as Capital Markets Advisor

GlobeNewswire Europe

View photo

.



SAN FRANCISCO - June 26, 2014 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), is pleased to announce that it has been selected as Capital Markets Advisor to CannLabs, Inc. (SDSPD). CannLabs, headquartered in Denver, is a full service testing laboratory and consultant for the cannabis industry.
 
CannLabs provides laboratory testing, consulting and research for cannabis growers, dispensaries and makers. The Company`s website allows customers to find certified products that have been tested, along with specific information about each product. Additionally, CannLabs uses their proprietary cloud-based technology and business intelligence solutions to consult with cannabis companies, customers and legislators, to offer them data-driven recommendations on safety and best practices in the burgeoning industry.
 
Merriman will provide CannLabs` management team with advice on strategies to grow the Company`s long term institutional shareholder base. Merriman Capital Markets Advisory Group clients benefit from corporate brokerage services, access to unique capital solutions, and a range of related initiatives intended to help companies accomplish their capital markets initiatives.
 
"We welcome CannLabs to our platform of Capital Markets Advisory clients," commented Douglas Rogers, Managing Director and Head of the Capital Markets Advisory Group at Merriman. Mr. Rogers continued, "CannLabs services are addressing the needs of an industry just beginning to become institutionalized in many states. We believe that the company`s scientific expertise, growth strategy, and strong management team should position CannLabs for success. As we begin working closely with CannLabs, we are looking forward to working and helping management achieve their capital markets objectives as they grow the Company. "

About Merriman Capital, Inc.
Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, as well as Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (MERR) and is the leading advisory firm for publicly traded, high-growth companies.
 
Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: http://www.digitalcapitalnetwork.com.
 
Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org/ and the Securities Investor Protection Corporation (SIPC) http://www.sipc.org/.

About CannLabs
CannLabs, Inc. is a solutions provider with intellectual property, proprietary cloud-based analytics and scientific methods to serve the cannabis industry. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence technology and other solutions required to serve the cannabis industry, and these include the first state-licensed laboratory in Denver, Colorado.
 
CannLabs enables growers, dispensaries and edible makers to implement best practices while furthering product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.
 
CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The Company provides client education around safe cultivation, identifying contamination problems, consulting on legal cases and the reformulation of cannabis products, throughout the U.S. and Canada.
 
The Company plans to license their solutions to new labs and other cannabis companies in states and provinces as legislation and testing mandates for legalization are approved. This will allow the Company to further scale its data analytics and consulting business across a broader geographic area. In addition, the CannLabs team will focus on research and development which will further drive value for their customers and provide incremental revenue opportunity. 
 
 
Note to Investors
This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K filed on March 31, 2014. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-K filed on March 31, 2014, together with this press release and the financial information contained herein, are available on our website, www.merrimanco.com. Please click on "Investor Relations."
 

# # #


At Merriman:
 
Douglas Rogers
Managing Director
Merriman Capital, Inc.
(415) 248-5612
 
Howard Bernstein
Chief Compliance Officer
Merriman Capital, Inc.
(415) 262-1377




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Merriman Holdings Inc. via GlobeNewswire

HUG#1803550
View Comments (0)